AllDocs -> cancers

Abstract. We have demonstrated anti-proliferation and anti-metastasis effects of both interferon- · and a histone deacetylase inhibitor, sodium butyrate, on human liver cancer cell lines. In this study, invasive ability of human liver cancer cell lines through the matrix-coated membrane was examined and inhibitory effect of interferon- · and sodium butyrate was investigated. Among six human liver cancer cell lines, HLE and HLF showed high invasive ability using the Matrigel invasion assay. This invasion ability was significantly inhibited by pretreatment of the cells with 1000 IU/ml of interferon- · or 2 mM of sodium butyrate. Gelatin zymography and the matrix metalloproteinase-2 and -9 activity assay showed that these two cell lines produce active- and pro-matrix metalloproteinase-2 and -9, and their activity was significantly ...

The 1996-2000 average annual age-adjusted incidence rate for invasive cancers of the liver and intrahepatic bile duct was almost three times higher in males than in females (6.8 compared to 2.4 per 100,000), and blacks of both sexes had higher rates compared to whites. There were 708 cases of liver /intrahepatic bile duct cancers diagnosed and reported among residents of Pennsylvania for 2000 – the highest annual figure recorded between 1991 and 2000. The annual age-adjusted incidence rates by sex and race for ten years (1991 through 2000) showed increasing rates among males, especially black males, and females of both races. The 1996-2000 average annual age-specific incidence rates show that black males have had the highest risks. During the period of 1996-2000, over 62 percent of the cases were diagnosed among residents 65 years of age or older. In 2000, over 57 percent of the staged liver /intrahepatic bile duct cancers were ...

Radio Frequency Ablation for Primary Liver Cancer Health Technology Scientific Literature and Policy Review Completed June 2004 1 Page 2 Radio Frequency Ablation Disclaimer This health technology scientific literature and policy review was prepared by the Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care for the Ontario Health Technology Advisory Committee and developed from analysis, interpretation and comparison of scientific research and/or technology assessments conducted by other organizations. It also incorporates, when available, Ontario data, and information provided by experts and applicants to the Medical Advisory Secretariat to inform the analysis. While every effort has been made to do so, this document may not fully reflect all scientific research available. Additionally, ...

T HE C LEVELAND C LINIC F OUNDATION F O R Y O U R I N F O R M A T I O N Radiofrequency Ablation: A Treatment Option for Inoperable Liver Cancer Study Results Show Increased Survival Results from a multicenter study led by Cleveland Clinic surgeon Allan Siperstein, M.D., showed that patients with inoperable primary or metastatic liver cancer lived significantly longer when treated with a combination of chemotherapy and radiofrequency ablation (RFA) rather than with chemotherapy alone. Results from a study presented at the American Society of Clinical Oncology in June 2003 showed that RFA in addition to chemotherapy dramatically improves patient survival. At three years, approximately 40 percent to 60 percent of patients treated with RFA were alive, ...

P2 CANCER . BASIC ASPECTS 78 Obstructive Jaundice Results in Increased Liver Expression of Uncoupling Protein 2 and Intact Skeletal Muscle Glucose Metabolism in the Rat Bengt Isaksson 1 , Catarina Rippe 2 , Rusana Simonoska 1 , Jan-Erik Holm 1 , Ralf Segersvärd 1 , Jörgen Larsson 1 , Charlotte Erlanson-Albertsson 2 , Johan Permert 1 Arvid Wretlind Laboratory for Metabolic and Nutritional Research 1 , Department of Surgery, Karolinska Institute at Huddinge University Hospital, S-141 86 Stockholm, Sweden, Department of Medical Chemistry 2 , Lunds University Hospital, Lund, Sweden Background and Aims : A majority of patients with pancreatic cancer have obstructive jaundice and diabetes with skeletal muscle insulin ...

447 March Road Kanata, Ontario Canada K2K 1X8 Tel: 613 592-2790 NEWS RELEASE March 21, 2000 Inoperable Primary Liver Cancer Treatment Receives Humanitarian Device Exemption TheraSphere’s Microscopic Glass Beads Offer Alternative to Chemotherapy in Inoperable Cases Kanata, Ontario, Canada - MDS Nordion, a global leader in radioisotope technology, received authorization from the US Food and Drug Administration to market TheraSphere , a non-surgical outpatient therapy that uses microscopic glass beads to deliver radiation therapy to treat inoperable hepatocellular carcinoma (HCC), a liver cancer . This form of liver cancer is one of the most common tumours in the world, affecting up to 10 percent of the population in sub-Saharan Africa and Southeast Asia. 1 At present, the incidence of HCC in the US is low, but is expected ...

504 JMAJ, November 2003—Vol. 46, No. 11 Need to Control Hepatitis, a Very Common Disease in Japan Following the discovery of hepatitis B virus in 1964, hepatitis viruses A and C were identi- fied in 1972 and 1989, respectively. The roles of these viruses in Japan have been increasingly well clarified. That is, the pathophysiology of the three types of viral hepatitis has been eluci- dated, and appropriate treatment measures have been established. In the past, it was a clinical practice at out- patient liver clinics in Japan to inform patients of changes in their serum GOT and GPT levels. Prediction, Prevention and Treatment of Liver Cancer JMAJ 46(11): 504–511, 2003 Masao OMATA Professor, Department of Gastroenterology, Graduate School of Medicine, University of Tokyo Abstract: Hepatitis virus infection has ...

Fox Chase Cancer Center 2003 Scientific Report 1 Clearance of Infected Hepatocytes During the Resolution of a Transient Hepadnavirus Infection. Mason, Aldrich, Saputelli, in collaboration with Summers, a Jilbert b Hepadnavirus infections in adults normally clear after a few months. Prior to clearance, every hepatocyte may be infected. Infection of every hepatocyte may also characterize chronic infections but, in this case, the immune response causes a persistent disease without clearing the virus. A goal of our research is therefore to characterize how virus is elimi- nated during resolution of transient infections and, in the long term, whether this same pro- cess can be induced, to cure chronic infections. To study the fate of infected hepatocytes during a transient infection, we infected woodchucks with woodchuck hepatitis ...

LIVER CANCER - All Sections LIVER CANCER What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells can travel to other parts of the body where they begin to grow and replace normal tissue. This process, called metastasis , occurs as the cancer cells ...

N N E E W W S S 4 February 2004 Revolutionary liver cancer treatment to be showcased at Medway The Medway NHS Trust is hosting a ground breaking clinical workshop on 17 February 2004 at the Medway Maritime Hospital, Gillingham which will include two live demonstrations of an exciting new procedure for the diagnosis and treatment of liver cancer . The internationally respected specialist, Professor R Lencioni of Pisa Hospital, Italy, will perform this procedure, which is based on Contrast Enhanced Ultrasound (CEUS) and Radiofrequency Ablation (RFA). The thrust of this new advance is local deposition of thermal energy directly to the tumour cells, which heats and destroys the cancerous tissue. Electrodes shaped like needles are inserted into the liver . This is achieved without making cuts and Ultrasound images allow the ...

Chapter 22: Liver cancer 213 Liver cancer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

Brochure More information from http://www.researchandmarkets.com/reports/6164 Medicines in Development for Liver Cancer Description: Database Table: Medicines in Development for Liver Cancer Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology and healthcare sectors. Over 600 database tables are now available from Research and Markets A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: ...

liver cancer Liver Cancer A leading cause of death in the world Can be primary or a metastatic site Seen more in other parts of the world incidence African American males 40 – 60 years old Cirrhosis Hepatitis B and C Causes of Liver Cancer Primary Trauma Nutritional deficits ...

P.O.Box 2345, Beijing 100023, China World J Gastroenterol 2003;9(4):706-709 Fax: +86-10-85381893 World Journal of Gastroenterology E-mail: wjg@wjgnet.com www.wjgnet.com Copyright © 2003 by The WJG Press ISSN 1007-9327 • LIVER CANCER • Right trisectionectomy for primary liver cancer Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Li Zhou Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Li Zhou, Department of General Surgery, Peking Union Medical College Hospital, Beijing 100032, China Correspondence to: Prof. Jing-An Rui, Department of General Surgery, Peking Union Medical College Hospital, Beijing 100032, China. rlzhou@mail.bjmu.edu.cn Telephone: +86-10-62091034 Fax: +86-10-62358270 Received: 2002-11-19 Accepted: 2003-01-02 Abstract AIM: To evaluate the value of right trisectionectomy, previously named right trisegmentectomy, in ...

Liver Cancer Jonathan M Hemli Thomas J Hugh Royal North Shore Hospital General Surgical Training Program (NSW), 3rd March 2004 Overview A large number of malignant lesions have been described in the liver , both of primary hepatic origin, and metastatic in nature (Table 1). The most common primary hepatic malignancy is hepatocellular carcinoma, accounting for over 85% of primary cancers of the liver , while intrahepatic cholangiocarcinoma is the next most common disease, constituting up to 10% of reported cases. Metastatic disease to the liver is considerably more common than primary hepatic malignancy. Hepatocellular Carcinoma Table 1. Malignant lesions of the liver Background Hepatocellular carcinoma (HCC) is one of the most commonly occurring solid tumours worldwide, with an estimated one million new ...

Intraarterial Irradiation for Inoperable Liver Cancer Information for patient Introduction • Intra-arterial irradiation has been developed in the treatment of inoperable liver tumours. This is to eradicate tumour cells by radiation. • Radiologist with special training in Interventional Radiology will perform this treatment in the Department of Radiology under image guidance. • The procedure involves the selective cannulation of the specific artery supplying the liver tumours and the subsequent delivery of radioactive particles (Yttrium-90). • Yttrium 90 particles emit high-energy electron, which kills the tumour cells in the vicinity. • About 5% of the patients receiving this treatment have their inoperable status converted to resectable cases. Procedure • Pretreatment assessment imaging such as computed tomography (CT) and angiography will be ...

l del file contenuto in http://www.hkbu.edu.hk/~10scprhk/Org-abstract/O-82.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:hMduNbAM8sUJ:www.hkbu.edu.hk/~10scprhk/Org-abstract/O-82.doc+allintitle:+liver+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle liver cancer Title: To elucidate the role of DLC2 in the development of hepatocellular carcinoma. Authors: Andy KL Fung1, Hongzhe Sun1, DY Jin2, Stephen SM Chung3 and Ben CB Ko1 From the 1Open Laboratory of Chemical Biology of the ...

NYS NYC 05 Staten Isl 04 Queens 03 Brooklyn 02 Bronx 01 Manhattan 62 Yates * 61 Wyoming * 60 Westchester 59 Wayne * 58 Washington * 57 Warren * 56 Ulster 55 Tompkins * 54 Tioga * 53 Sullivan * 52 Suffolk 51 Steuben * 50 Seneca * 49 Schuyler * 48 Schoharie * 47 Schenectady * 46 Saratoga * 45 St Lawrence * 44 Rockland 43 Rensselaer * 42 Putnam * 41 Otsego * 40 Oswego * 39 Orleans * 38 Orange * 37 Ontario * 36 Onondaga 35 Oneida * 34 Niagara 33 Nassau 32 Montgomery * 31 Monroe 30 Madison * 29 Livingston * 28 Lewis * 27 Jefferson * 26 Herkimer * 25 Hamilton * 24 Greene * 23 Genesee * 22 Fulton * 21 Franklin * 20 Essex * 19 Erie 18 Dutchess * 17 Delaware * 16 Cortland * 15 Columbia * 14 Clinton * 13 ...

1 Surgical Pathology Cancer Case Summary LIVER : Cytology/Biopsy Patient name: Cytology/Surgical pathology number: MACROSCOPIC (check all that apply) SPECIMEN TYPE Cytology (FNA) Needle biopsy Incisional biopsy TUMOR SITE Right lobe Left lobe Unknown Other ADEQUACY OF SPECIMEN (if applicable) Satisfactory Limited (see COMMENT) Unsatisfactory (see COMMENT) COMMENT _ _ _ _ MICROSCOPIC (check all that apply) HISTOLOGIC TYPE Cannot be assessed Hepatocellular carcinoma, NOS Fibrolamellar hepatocellular carcinoma Combined hepatocellular cholangiocarcinoma Cholangiocarcinoma Other (specify:) Page 2 2 HISTOLOGIC GRADE Not applicable GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated ...

PO Box 2345, Beijing 100023, China World J Gastroenterol 2004;10(9):1246-1249 Fax: +86-10-85381893 World Journal of Gastroenterology E-mail: wjg@wjgnet.com www.wjgnet.com Copyright © 2004 by The WJG Press ISSN 1007-9327 • GASTRIC CANCER • Role of nucleostemin in growth regulation of gastric cancer , liver cancer and other malignancies Si-Jin Liu, Zi-Wei Cai, Ya-Jun Liu, Mei-Yu Dong, Li-Qiu Sun, Guo-Fa Hu, Ying-Yun Wei, Wei-De Lao Si-Jin Liu, Guo-Fa Hu, Ying-Yun Wei, Wei-De Lao, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100080, China Zi-Wei Cai, Li-Qiu Sun, Institute of Biology of Self-protection, Mudanjiang Medical College, Mudanjiang 157011, Heilongjiang Province, China Ya-Jun Liu, Department of Spine, Beijing Jishuitan Hospital, Peking University, Beijing 100035, China Mei-Yu Dong, Tianjin Institute ...

This chapter is comprised of three sections. The first section reviews how factors that alter liver metabolism can cause toxicity from anti- cancer drugs. Because of the high incidence of liver toxicity and the high case-fatality rate, the second section will be an in-depth examination of liver toxicity in hematopoietic stem cell transplantation. The final sec- tion will review hepatotoxicity from individual anticancer drugs. ALTERATIONS IN HEPATIC METABOLISM OF DRUGS Chemotherapeutic agents usually have a narrow therapeutic index. Thus, factors that change disposition of these drugs may easily alter efficacy or cause toxicity. Specific recommendations about dose reduc- tion in patients with impairment or alteration of hepatic metabolism will be discussed in other chapters. This section will discuss the impact of various factors on disposition of anticancer drugs by the liver (Table 151.1) ...